Brokerages Set Ryan Specialty Holdings, Inc. (NYSE:RYAN) Price Target at $74.40

Ryan Specialty Holdings, Inc. (NYSE:RYAN - Get Free Report) has been given a consensus recommendation of "Hold" by the twelve analysts that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $74.40.

Several equities research analysts have recently weighed in on the stock. Keefe, Bruyette & Woods reduced their target price on shares of Ryan Specialty from $79.00 to $77.00 and set an "outperform" rating on the stock in a research note on Friday, January 10th. Morgan Stanley began coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price target on the stock. Barclays increased their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a research report on Thursday, November 21st. Finally, Wells Fargo & Company reduced their price target on shares of Ryan Specialty from $68.00 to $64.00 and set an "equal weight" rating for the company in a research report on Tuesday, January 14th.

Ryan Specialty Price Performance

Shares of RYAN stock traded up $0.14 during mid-day trading on Wednesday, hitting $68.75. The company had a trading volume of 933,210 shares, compared to its average volume of 955,283. Ryan Specialty has a 52-week low of $44.84 and a 52-week high of $75.97. The stock's 50 day moving average price is $65.53 and its 200-day moving average price is $67.14. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company has a market capitalization of $18.00 billion, a P/E ratio of 89.29, a P/E/G ratio of 1.19 and a beta of 0.72.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction on Friday, December 13th. The shares were sold at an average price of $67.39, for a total transaction of $2,358,650.00. Following the sale, the director now owns 65,100 shares of the company's stock, valued at $4,387,089. The trade was a 34.97 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total transaction of $500,058.40. Following the sale, the director now directly owns 78,149 shares in the company, valued at approximately $5,539,201.12. This trade represents a 8.28 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 323,506 shares of company stock valued at $21,407,851. 11.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Hollencrest Capital Management purchased a new position in shares of Ryan Specialty during the 3rd quarter worth $25,000. Rakuten Securities Inc. purchased a new stake in Ryan Specialty in the 4th quarter valued at about $27,000. Assetmark Inc. purchased a new stake in Ryan Specialty in the 3rd quarter valued at about $34,000. Kapitalo Investimentos Ltda purchased a new stake in Ryan Specialty in the 4th quarter valued at about $36,000. Finally, Principal Securities Inc. raised its holdings in Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock valued at $43,000 after buying an additional 415 shares during the period. Hedge funds and other institutional investors own 84.82% of the company's stock.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.